| Term 
 | Definition 
 
        | Manufactured by beta cells of pancreas, controls storage and use of amino acids and fatty acids. Lowers blood glucose levels by inhibiting liver glucose production. MA: helps glucose molecules enter the cells of muscle and adipose tissue; stimulates glycogen synthesis by liver; promotes protein synthesis; helps body store fat by preventing its breakdown for energy Use: controlling type 1 diabetes melitus Adverse Rx: hypoglycemia and hyperglycemia CI: hypoglycemia, hypersensitivity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MA:Lowers blood glucose by stimulating the beta cells of pancreas to release insulin Use: adjunct to diet to lower blood glucose in type 2 diabetes; adjunct to insulin theray in certain patients with type 1 diabetes Adverse Rx: anorexia, nausea, vomitting, epigastric discomfort, heartburn, hypoglycemia CI: hypersensitivity, diabetic ketoacidosis, severe infection, severe endocrine disease   |  | 
        |  | 
        
        | Term 
 
        | Diabense (chlorpropamide) |  | Definition 
 
        | MA: lowers blood glucose by stimulating beta cells of pancreas to release insulin Use: adjunct to diet in type 2 diabetes Adverse Rx: Anorexia, nausea, vomitting, epigastric discomfort, heartburn, hypoglycemia CI: hypersensitivity, diabetic ketoacidosis, severe infection, severe endocrin disease, coronary artery disease, liver or renal dysfunction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MA: lowers blood glucose by stimulating beta cell sin pancreas to release insulin Use: type 2 diabetes, adjunct to insulin therapy in stabilization of certain cases of insulin-dependent diabetes (type 1) Adverse Rx: Anorexia, nausea, vomitting, epigastric discomfort, heartburn, diarrhea, hypoglycemia, allergic skin reaction CI: hypersensitivity, diabetic ketoacidosis, severe infection, severe endocrine disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MA: lowers blood glucose by stimulating beta cells of pancrease to release insulin Use: Type 2 diabetes, adjunct to insulin therapy in stabilization of certain cases of insulin-dependent diabetes (type 1) Adverse Rx: Anorexia, nausea, vomitting, epigastric discomfort, heartburn, hypoglycemia CI: hypersensitivity, diabetic ketoacidosis, severe infection, severe endocrine disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MA: lowers blood sugar by delaying digestion and absorption of carbs Use: Type 2 diabetes, combination therapy with sulfonylurea to enhance glycemic control Adverse Rx: flatulence, diarrhea, abdominal pain CI: hypersensitivity, diabetic ketoacidosis, cirrhosis, IBS, colonic ulceration, partial intestinal obstruction, chronic intestinal disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MA: Sensitizes liver to circulating insulin levels and reduces hepatic glucose production Use: Type 2 diabetes, with sulfonylurea or insulin to improve glycemic control Adverse Rx: anorexia, nausea, vomitting, epigastric pain, heartburn, diarrheam hypoglycemia, allergic skin reaction CI: heart failure, renal diseasem hypersensitivity to metformin, acute or chronic metabolic acidosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MA: decrease hepatic glucogenesis and increase insulin-dependent muscle glucose uptake Use: Type 2 diabetes, in combination with metformin to improve glycemic control Adverse Rx: Headache, pain, diarrhea, hypoglycemia, hyperglycemia, fatigue, infections CI: hypersensitivity, heart failure, pregnancy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MA: glucose elevation Use: hypoglycemia caused by hyperinsulinism Adverse Rx: sodium and fluid retention, hyperglycemia, glycosuria, tachycardia, congestive heart failure CI: |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MA: glucose elevation Use: hypoglycemia Adverse Rx: nausea, vomitting, generalized allergic reactions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MA: synthetic human growth hormone Use: growth failure caused by deficiency of pituitary growth hormone in children Adverse Rx: failure to respond to therapy due to development of antibodies, hypothyroidism, insulin resistance, swelling of joints, joint and/or muscle pain CI: hypersensitivity, epiphyseal closure or underlying cranial lesions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MA: regulate reabsorption of water by kidneys Use: diabetes insipidus, prevention and Tx of postoperative abdominal distention, to dispel gas interfering with abdominal x-ray examination Adverse Rx: tremor, sweating, vertigo, nausea, comitting, abdominal cramps, hypersensitivity, headache CI: chronic renal failure, increased blood urea nitrogen, allergy to beef or pork proteins |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MA: stimulates adrenal cortex to produce and secrete adrenocortical hormones Use: diagnostic testing of adrenocortical function, nonsuppurative thyroiditis, hypercalcemia associated with cancer, acute exacerbations of MC Adverse Rx: Table 23-2 CI: adrenocortical insufficiency or hyperfunction, allergy to pork, systemic fungal infections, ocular herpes simplex, scleroderma, osteoporosis, hypertension |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  |